Jayeeta Roy1, Jayanta Kumar Mitra, Arnab Pal. 1. Department of Obstetrics & Gynaecology, College of Medicine and JNM Hospital, WBUHS, Kalyani, West Bengal, India.
Abstract
BACKGROUND: Eclampsia manifests as seizures and is unique to the pregnant state. It remains an important cause of maternal mortality especially in resource-challenged countries that lack access to prenatal care. AIMS: The aim of our study was to compare maternal and foetal outcomes in mothers with eclampsia with the administration of eithermagnesium sulphate or phenytoinin a resource- challenged situation. METHOD: The work was conducted from January 2012 to December 2012. A total of 80 patients were assigned alternately to two groups - one group was treated with magnesium sulphate (Group-M; n=40), and the other treated with phenytoin (Group-P; n=40) (Figure 1). The magnesium sulphate was administered according to Pritchard's regimen; phenytoin administered according to Ryan's regimen. With either regimen, anticonvulsant therapy was continued for 24 hours postpartum or 24 hours after the last convulsion, whichever was later. RESULTS: Fifty-four per cent of patients regained consciousness within eight hours of treatment onset in Group-P compared to 5.3 per cent in Group-M (p=0.0001, χ(2)=19.24). Seven patients in Group-P had recurrence of convulsions as compared to none of the 40 women assigned to Group-M (p=0.032, χ(2)=4.62). The incidence of Caesarean section was greater (62.5 per cent) in Group-M compared to Group-P (25 per cent; p=0.001, χ(2)= 9.96). No statistically significant differences were found in the foetal outcomes between the two groups. CONCLUSION:Phenytoin use may be reconsidered in selective cases in low and middle income countries (LMIC) as it has been found simpler to use, has several benefits and also curtails treatment cost. Magnesium sulphate is substantially more effective than phenytoin with regard to recurrence of convulsions. Proper training in the management of eclampsia should be given to all health care workers to ensure appropriate management of eclamptic mothers. Thus, the treatment of this disease calls for more research especially in resource-challenged settings.
RCT Entities:
BACKGROUND:Eclampsia manifests as seizures and is unique to the pregnant state. It remains an important cause of maternal mortality especially in resource-challenged countries that lack access to prenatal care. AIMS: The aim of our study was to compare maternal and foetal outcomes in mothers with eclampsia with the administration of either magnesium sulphate or phenytoin in a resource- challenged situation. METHOD: The work was conducted from January 2012 to December 2012. A total of 80 patients were assigned alternately to two groups - one group was treated with magnesium sulphate (Group-M; n=40), and the other treated with phenytoin (Group-P; n=40) (Figure 1). The magnesium sulphate was administered according to Pritchard's regimen; phenytoin administered according to Ryan's regimen. With either regimen, anticonvulsant therapy was continued for 24 hours postpartum or 24 hours after the last convulsion, whichever was later. RESULTS: Fifty-four per cent of patients regained consciousness within eight hours of treatment onset in Group-P compared to 5.3 per cent in Group-M (p=0.0001, χ(2)=19.24). Seven patients in Group-P had recurrence of convulsions as compared to none of the 40 women assigned to Group-M (p=0.032, χ(2)=4.62). The incidence of Caesarean section was greater (62.5 per cent) in Group-M compared to Group-P (25 per cent; p=0.001, χ(2)= 9.96). No statistically significant differences were found in the foetal outcomes between the two groups. CONCLUSION:Phenytoin use may be reconsidered in selective cases in low and middle income countries (LMIC) as it has been found simpler to use, has several benefits and also curtails treatment cost. Magnesium sulphate is substantially more effective than phenytoin with regard to recurrence of convulsions. Proper training in the management of eclampsia should be given to all health care workers to ensure appropriate management of eclamptic mothers. Thus, the treatment of this disease calls for more research especially in resource-challenged settings.
Entities:
Keywords:
Eclampsia; comparison; low and middle income countries; magnesium sulphate; maternal mortality; phenytoin; resource challenged
Authors: Emmanuel Bujold; Sean C Blackwell; Israel Hendler; Susan Berman; Yoram Sorokin; Robert J Gauthier Journal: Am J Obstet Gynecol Date: 2004-11 Impact factor: 8.661
Authors: Laura Bennet; Robert Galinsky; Vittoria Draghi; Christopher A Lear; Joanne O Davidson; Charles P Unsworth; Alistair J Gunn Journal: J Physiol Date: 2018-04-16 Impact factor: 5.182
Authors: Alfonsus Adrian Hadikusumo Harsono; Achmadi Achmadi; Muhammad Ilham Aldika Akbar; Hermanto Tri Joewono Journal: Am J Case Rep Date: 2018-09-25